Trademark: 79139380
Word
XL-PROTEIN
Status
Dead
Status Code
404
Status Date
Tuesday, April 25, 2023
Serial Number
79139380
Registration Number
4634784
Registration Date
Tuesday, November 11, 2014
Mark Type
4000
Filing Date
Friday, April 26, 2013
Published for Opposition
Tuesday, August 26, 2014
Cancellation Date
Wednesday, April 26, 2023

Trademark Owner History
XL-protein GmbH - Original Registrant

Classifications
5 [ Pharmaceutical and veterinary preparations, preparations for human medical purposes for use in treating growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; ] sanitary preparations for medical purposes; [ dietetic substances adapted for medical use, namely, nutritional supplements containing proteins, peptides, food for babies; ] preparations for destroying vermin; fungicides, herbicides [ ; pharmaceutical and diagnostic preparations for medical, dental and forensic purposes and for purposes of forensic medicine and laboratory medicine, namely, pharmaceutical and diagnostic preparations for diagnosis, prevention, treatment or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; testing reagents in kit form for medical, dental and forensic purposes and for purposes of forensic medicine and laboratory medicine, namely, medical and forensic diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells and for performing of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventive, curative and palliative purposes for preventing, treating or curing of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; medical biomarkers, in particular for preventative, diagnostic, prognostic or predictive purposes, namely, polypeptide sequences; medical preparations, namely, kits for laboratory medicine in particular for preventive, diagnostic, prognostic or predictive purposes, namely, diagnostic kits consisting primarily of proteins, buffers, and reagents for use in detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; biomolecules (targets) for medical purposes, namely, proteins, peptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposes, namely, reagents for detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; preparations for health care, namely, for diagnosis, prevention, treatment, or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases ]
1 [ Chemical and biochemical preparations for use in research and laboratories, except for medical and veterinary use, as well as for industrial and scientific use; ] unprocessed artificial resins, unprocessed plastics
42 [ Scientific and technological services and research, namely, scientific research, analysis, testing, in the field of chemistry, genetics, biology, biotechnology and biochemistry; technical services, namely, computer diagnostic services in the field of DNA, RNA and protein expression, detection and analysis and respective design services, in particular in the field of chemistry, genetics, biology, biotechnology and biochemistry; industrial analysis and research services in the field of medical, dental, forensic and scientific research; ] design and development of computer hardware [ and software; services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations and preparation of scientific opinions; quality checking, namely, quality evaluation services for the medical and pharmaceutical industry; design and development of programs for data processing; consultancy for scientific, laboratory and research purposes in the field of chemistry, genetics, biology, biotechnology and biochemistry; scientific services of a technical measuring and test laboratory; technological consulting services pertaining to scientific and industrial scientific research in the fields of generation, technical processing and technical analysis of biomaterials and medically relevant data ]
In the statement, Class 1, 5 and 42 has been updated in accordance with the F-note dated 1/7/2020.
Color is not claimed as a feature of the mark.
The word(s) "XL-protein" has no meaning in a foreign language.

Trademark Events
Nov 20, 2023
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Nov 20, 2023
Death Of International Registration
Jul 17, 2022
Total Invalidation Processed By The Ib
May 20, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
May 20, 2022
Invalidation Processed
Jan 28, 2022
Total Invalidation Of Reg Ext Protection Created
May 28, 2021
Cancelled Section 71
Sep 23, 2020
Invalidation Reviewed - No Action Required By Office
Sep 23, 2020
Partial Invalidation Of Reg Ext Protection Created
Jan 14, 2020
Limitation From The Ib Examined And Entered
Jan 13, 2020
Correction Under Section 7 ¿ Processed
Jan 13, 2020
Assigned To Paralegal
Nov 11, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Aug 9, 2019
Limitation Of Goods Received From Ib
Jul 13, 2017
New Representative At Ib Received
Apr 24, 2015
Final Decision Transaction Processed By Ib
Apr 2, 2015
Final Disposition Notice Sent To Ib
Apr 2, 2015
Final Disposition Processed
Feb 11, 2015
Final Disposition Notice Created, To Be Sent To Ib
Nov 11, 2014
Registered-Principal Register
Aug 26, 2014
Official Gazette Publication Confirmation E-Mailed
Aug 26, 2014
Published For Opposition
Aug 22, 2014
Notification Processed By Ib
Aug 6, 2014
Notification Of Possible Opposition Sent To Ib
Aug 6, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 6, 2014
Notification Of Notice Of Publication E-Mailed
Jul 18, 2014
Law Office Publication Review Completed
Jul 18, 2014
Approved For Pub - Principal Register
Jun 26, 2014
Teas/Email Correspondence Entered
Jun 26, 2014
Correspondence Received In Law Office
Jun 16, 2014
Assigned To Lie
Jun 4, 2014
Teas Response To Office Action Received
Jun 4, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 4, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 31, 2013
Refusal Processed By Ib
Dec 13, 2013
Application Filing Receipt Mailed
Dec 10, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Dec 10, 2013
Refusal Processed By Mpu
Dec 10, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Dec 9, 2013
Non-Final Action Written
Dec 9, 2013
Assigned To Examiner
Dec 9, 2013
New Application Office Supplied Data Entered
Dec 6, 2013
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24